Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sopharma Trading ADXBUL:SFT 79 Receivables Turnover is 2.37 as of Mar. 2026. GuruFocus rates XBUL:SFT with a GF Score™ of 79/100 and a GF Value™ of €7.78 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 118 Medical Distribution companies, Sopharma Trading AD ranks better than 85.59% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Sopharma Trading AD's Revenue for the
three
months ended in Mar. 2026 was €303 Mil. Sopharma Trading AD's average Accounts Receivable for the
three
months ended in Mar. 2026 was €128 Mil.
Hence, Sopharma Trading AD's Receivables Turnover for the
three
months ended in Mar. 2026 was 2.37.
Sopharma Trading AD (XBUL:SFT) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Sopharma Trading AD Receivables Turnover Related Terms
Sopharma Trading AD Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Sopharma Trading AD's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XBUL:SFT vs MCK, COR, CAH: Receivables Turnover Comparison
For the Medical Distribution subindustry, Sopharma Trading AD's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma Trading AD Receivables Turnover vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Sopharma Trading AD's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sopharma Trading AD (XBUL:SFT) has a Receivables Turnover of 2.37 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Sopharma Trading AD and its competitors. According to the industry distribution chart, Sopharma Trading AD ranks #17 out of 118 companies in the Medical Distribution industry, placing it in the top 14.4%.
Is Sopharma Trading AD's Receivables Turnover too high?
Sopharma Trading AD's current Receivables Turnover is 2.37. The Medical Distribution industry median Receivables Turnover is 4.72. Sopharma Trading AD's value of 2.37 is 49.8% below this industry median. Based on the distribution chart, Sopharma Trading AD ranks #17 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Sopharma Trading AD has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sopharma Trading AD's Receivables Turnover compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sopharma Trading AD ranks #17 out of 118 companies for Receivables Turnover. This places Sopharma Trading AD in the top 14% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 4.72. Sopharma Trading AD's value of 2.37 is 49.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Distribution company?
The median Receivables Turnover among Medical Distribution companies is 4.72, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sopharma Trading AD's current Receivables Turnover of 2.37 is 49.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Sopharma Trading AD and its competitors. For the Medical Distribution industry, the median Receivables Turnover is 4.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sopharma Trading AD's current Receivables Turnover is 2.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma Trading AD stock overvalued right now?
Based on GuruFocus' analysis, Sopharma Trading AD (XBUL:SFT) is currently considered Significantly Undervalued. The stock's GF Value™ is €7.78, compared to a current price of €2.96 — trading 62% below its estimated fair value. The current Receivables Turnover is 2.37 and 49.8% below the Medical Distribution industry median of 4.72. Sopharma Trading AD's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Sopharma Trading AD (XBUL:SFT), the current Receivables Turnover is 2.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sopharma Trading AD (XBUL:SFT) Overvalued in 2026?
Based on GuruFocus' analysis, Sopharma Trading AD stock appears to be undervalued.
The current stock price of €2.96 is trading 62% below its estimated GF Value™ of €7.78.
GuruFocus considers Sopharma Trading AD to be Significantly Undervalued.
Key valuation signals for XBUL:SFT:
Receivables Turnover: 2.37
GF Value™: €7.78 vs. price of €2.96 (62% below fair value)
Industry Position: 49.8% below the Medical Distribution median (#17 of 118)
No single metric tells the full story. See the XBUL:SFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.
79GF Score
Get the complete analysis for XBUL:SFT
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XBUL:SFT has been successfully added to your 
